Mitsubishi Tanabe Pharma Corporation Provides Revenue Guidance for the Full Year of 2017
December 04, 2017
Share
Mitsubishi Tanabe Pharma Corporation provided revenue guidance for the full year of 2017. For the period, the company expects revenue to be JPY 315.4 billion.
Mitsubishi Tanabe Pharma Corporation is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The medical supplies business is engaged in the research, development, manufacture and sale of ethical pharmaceutical and non-prescription drugs. The Company's subsidiaries receive raw materials from the company and sell products locally.